Brief by Shorts91 Newsdesk / 07:49pm on 11 Dec 2024,Wednesday International
Bashar al-Assad’s regime profited $5B annually from Captagon, a potent amphetamine fueling Middle Eastern drug markets and warfare. Dubbed the "poor man's cocaine," Captagon accounted for 80% of global supply, with production linked to Assad's family and military. Recent reports indicate a 90% drop in production after the collapse of Assad’s regime, with operations shifting to small compounds in Lebanon under Iran-backed Hezbollah. Experts warn of a potential resurgence, as Iraqi militias may fill the void. Captagon’s addictive properties and role in combat make it a tool of both revenue and terror, raising global security concerns.
